NCT00369356View on ClinicalTrials.gov

Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

January 31, 2011

Conditions
Coronary Artery DiseaseIschemic Heart DiseaseAtherosclerosis
Interventions
DRUG

Prednisone

Bare metal stenting with administration of oral prednisone as described in the protocol

DEVICE

Drug eluting coronary stent

Stenting with DES (Cypher or Taxus)

DEVICE

Bare metal coronary stent

Stenting with BMS only

Trial Locations (5)

10100

Ospedale San Giovanni Bosco, Torino

20089

Istituto Clinico Humanitas, Milan

28100

Ospedale Maggiore della Carità, Novara

37126

Università di Verona, Verona

00149

European Hospital, Rome

All Listed Sponsors
collaborator

Regione Piemonte

OTHER

lead

Universita di Verona

OTHER

NCT00369356 - Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis | Biotech Hunter | Biotech Hunter